<< Achillion Pharmaceuticals receives NIH SBIR grant for study of novel antibacterial compound series | Health IT Now! Coalition panel discussion: Develop affordable access to broadband and healthcare >>
Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Filipino | Русский | Svenska | Polski

Midroog rates Elbit Imaging's new series of debentures "A2/Stable"

Published on March 18, 2010 at 7:36 AM · No Comments

Elbit Imaging Ltd. ("EI") (NASDAQ: EMITF) announced today that Midroog Ltd., an affiliate of Moody's Investors Services, has informed EI that its "A2/Stable" rating, on a local scale, would also apply to a new series of debentures in an aggregate principal amount of up to NIS 100 million that EI may issue to repay principal amounts of debt that comes due in 2010. This credit rating would also apply to additional debentures in the new series in an aggregate principal amount of up to NIS 400 million that EI may issue in exchange for outstanding debentures, subject to certain conditions.

EI has made no decision with respect to any future debt offering, and there is no certainty that any such debt offering will be executed. Any future debt offering, if made, will be made in Israel to residents of Israel only, and any debt instruments that may be offered will not be registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from U.S. registration requirements.

SOURCE Elbit Imaging Ltd.

Posted in:

Tags: ,

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading